Tandutinib
CAS No. 387867-13-2
Tandutinib ( MLN-518;MLN518;CT53518;MLN0518;MLN-0518;CT-53518 )
Catalog No. M14334 CAS No. 387867-13-2
A potent inhibitor of FLT3, Kit and PDGFR with IC50 of 0.22, 0.17 and 0.2 uM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 34 | In Stock |
|
50MG | 49 | In Stock |
|
100MG | 66 | In Stock |
|
200MG | 92 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTandutinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent inhibitor of FLT3, Kit and PDGFR with IC50 of 0.22, 0.17 and 0.2 uM, respectively.
-
DescriptionA potent inhibitor of FLT3, Kit and PDGFR with IC50 of 0.22, 0.17 and 0.2 uM, respectively; displays 15-20-fold less potent activity against CSF-1R; inhibits IL-3-independent cell growth and FLT3-ITD autophosphorylation with IC50 of 10-100 nM, induces apoptosis and inhibits FLT3-ITD phosphorylation, cellular proliferation and signaling through MAPK and PI3K pathways; exhibits ativity in murine models of FLT3-ITD-mediated disease.Brain Cancer Phase 2 Discontinued
-
SynonymsMLN-518;MLN518;CT53518;MLN0518;MLN-0518;CT-53518
-
PathwayTyrosine Kinase
-
TargetFLT3
-
Recptorc-Kit;CSF-1R;FLT3;PDGFRβ;Src
-
Research AreaCancer
-
IndicationBrain Cancer
Chemical Information
-
CAS Number387867-13-2
-
Formula Weight562.70
-
Molecular FormulaC31H42N6O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 36 mg/mL
-
SMILESO=C(N1CCN(C2=C3C=C(OC)C(OCCCN4CCCCC4)=CC3=NC=N2)CC1)NC5=CC=C(OC(C)C)C=C5
-
Chemical Name1-Piperazinecarboxamide, 4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kelly LM, et al. Cancer Cell. 2002 Jun;1(5):421-32.
2. Pandey A, et al. J Med Chem. 2002 Aug 15;45(17):3772-93.
3. Griswold IJ, et al. Blood. 2004 Nov 1;104(9):2912-8.
4. Clark JJ, et al. Blood. 2004 Nov 1;104(9):2867-72.
2. Pandey A, et al. J Med Chem. 2002 Aug 15;45(17):3772-93.
3. Griswold IJ, et al. Blood. 2004 Nov 1;104(9):2912-8.
4. Clark JJ, et al. Blood. 2004 Nov 1;104(9):2867-72.
molnova catalog
related products
-
CGS 27023A
CGS 27023A is a non-peptidic, potent, and orally active stromelysin inhibitor.
-
Trovirdine
Trovirdine is a thiourea non-nucleoside reverse transcriptase inhibitor.
-
Quizartinib
Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.